The Return of a Forgotten Threat: Measles and the Fragile State of US Public Health
For three decades, measles was a rare sight in the United States. But a concerning trend is unfolding: the disease is not only back, but it’s becoming increasingly entrenched, signaling a broader vulnerability in the nation’s ability to manage infectious disease threats.
A Year of Continuous Transmission
The resurgence began in early 2025 with an outbreak in Texas, lasting through August. Before that outbreak was contained, modern cases emerged on the Utah and Arizona border, and in South Carolina, where the situation dramatically worsened in January 2026 and continues to spread. As of March 6, 2026, the CDC has confirmed 1,281 measles cases across 31 states in 2026, with 12 new outbreaks reported. A staggering 89% of these cases are linked to existing outbreaks, originating in 2025 and 2026.
The Role of Declining Vaccination Rates
The root cause of this resurgence is declining vaccination rates. While approximately 90% of the US population has received the MMR vaccine, rates fall below 60% in some regions. Herd immunity, requiring around 95% vaccination coverage, has not been consistently maintained nationally or locally since 2019-2020. The US may lose its measles elimination status, a designation achieved in 2000, with a decision originally scheduled for April 2026, now postponed to November 2026 by the Pan American Health Organization.
Beyond the Immediate Health Risks
Measles isn’t just a childhood illness; it carries serious, long-term consequences. In 2025, three deaths were attributed to measles in the US – the highest number in 25 years. Approximately 11% of confirmed cases in 2025 required hospitalization. Complications can include pneumonia, encephalitis (potentially leading to deafness or intellectual disabilities), and even a rare, fatal progressive dementia called subacute sclerosing panencephalitis (SSPE), which can develop years after the initial infection. A school-age child in Los Angeles recently died from SSPE after being infected with measles as an infant.
The Economic Burden of Outbreaks
The economic costs of measles outbreaks are substantial. Containing outbreaks can cost tens of thousands of dollars per case. A 2018-2019 outbreak in Washington state, involving 72 cases, cost $3.2 million. A 1% drop in MMR coverage could cost the US billions of dollars across healthcare systems and the economy.
A Warning Sign for Public Health Preparedness
The return of measles serves as a warning about the nation’s broader capacity to handle infectious disease threats. The same strategies used to control measles – vaccination, case detection, isolation, contact tracing, and safe treatment – are essential for managing other infectious diseases. However, public trust in these measures, and in the Centers for Disease Control and Prevention, is eroding. Less than half of those polled in early 2026 trust the government to provide reliable vaccine information.
FAQ: Measles and Current Outbreaks
Q: How serious is measles?
A: Measles is a highly contagious and potentially serious disease that can lead to complications like pneumonia, encephalitis, and even death.
Q: What is herd immunity and why is it important?
A: Herd immunity occurs when a large percentage of the population is immune to a disease, protecting those who cannot be vaccinated. Around 95% immunity is needed to prevent widespread outbreaks.
Q: What is the current status of measles elimination in the US?
A: The US is at risk of losing its measles elimination status, a designation it achieved in 2000, due to sustained transmission of the virus.
Q: What can I do to protect myself and my family?
A: Ensure you and your family are up-to-date on the MMR vaccine. If you suspect you or someone you grasp has measles, contact a healthcare provider immediately.